950200 — Psomagen Income Statement
0.000.00%
Last trade - 00:00- KR₩71bn
- KR₩72bn
- $32.01m
- 17
- 25
- 32
- 10
Annual income statement for Psomagen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 16.1 | 25 | 33.6 | 24.7 | 32 |
| Cost of Revenue | |||||
| Gross Profit | -0.051 | 5.13 | 9.35 | 5.72 | 7.02 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 24.8 | 31.7 | 35.1 | 28 | 36.6 |
| Operating Profit | -8.71 | -6.76 | -1.53 | -3.31 | -4.57 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -18.3 | -6.17 | -0.807 | -3.36 | -4.56 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -18.3 | -6.17 | -0.811 | -3.37 | -4.57 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -18.3 | -6.17 | -0.811 | -3.29 | -4.12 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -18.3 | -6.17 | -0.811 | -3.29 | -4.12 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.2 | -0.324 | -0.032 | -0.146 | -0.195 |
| Dividends per Share |